Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria - Metz, Martin (Fraunhofer Institute for Translational Medicine and Pharmacology ITMP (Berlin, Alemanya)) ; Bernstein, Jonathan (University of Cincinnati College of Medicine and Bernstein Clinical Research Center) ; Giménez-Arnau, Ana M 1961- (Institut Hospital del Mar d'Investigacions Mèdiques) ; Hide, Michihiro (Hiroshima City Hospital) ; Maurer, Marcus (Fraunhofer Institute for Translational Medicine and Pharmacology ITMP) ; Sitz, Karl (Little Rock Allergy and Asthma Clinic) ; Soong, Weily (AllerVie Health-Alabama Allergy and Asthma Center) ; Sussman, Gordon (University of Toronto) ; Hua, Eva (Shanghai Novartis Trading Ltd) ; Barve, Avantika (Novartis Pharmaceuticals Corporation) ; Barbier, Nathalie (Novartis Pharma AG) ; Balp, Maria Magdalena (Novartis Pharma AG) ; Severin, Thomas (Novartis Pharma AG) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.